Cargando…

Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome

Coronavirus disease 2019 (COVID-19), a pandemic disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), is growing at an exponential rate worldwide. Manifestations of this disease are heterogeneous; however, advanced cases often exhibit various acute respiratory distress s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Feng, Ichim, Thomas E, Pingle, Sandeep, Jones, Lawrence D, Kesari, Santosh, Ashili, Shashaanka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596438/ https://www.ncbi.nlm.nih.gov/pubmed/33178392 http://dx.doi.org/10.4252/wjsc.v12.i10.1067

Ejemplares similares

Traumatic brain injury and immunological outcomes: the double-edged killer
por: Datta, Souvik, et al.
Publicado: (2023)

Exploring the role of cerebrospinal fluid as analyte in neurologic disorders
por: Pingle, Sandeep C, et al.
Publicado: (2023)

Anomaly Detection Framework for Wearables Data: A Perspective Review on Data Concepts, Data Analysis Algorithms and Prospects
por: Sunny, Jithin S., et al.
Publicado: (2022)

MTAP loss: a possible therapeutic approach for glioblastoma
por: Patro, C. Pawan K., et al.
Publicado: (2022)

Smart Consumer Wearables as Digital Diagnostic Tools: A Review
por: Chakrabarti, Shweta, et al.
Publicado: (2022)

Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines
por: Lin, Feng, et al.
Publicado: (2023)

Binned Data Provide Better Imputation of Missing Time Series Data from Wearables
por: Chakrabarti, Shweta, et al.
Publicado: (2023)

Fibroblasts as a practical alternative to mesenchymal stem cells
por: Ichim, Thomas E., et al.
Publicado: (2018)

Intravenous Administration of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC) for Acute Respiratory Distress Syndrome Due to COVID-19 Infection
por: Perez, Jesus A, et al.
Publicado: (2023)

Designing neoantigen cancer vaccines, trials, and outcomes
por: Biswas, Nupur, et al.
Publicado: (2023)

MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies
por: Dhas, Yogita, et al.
Publicado: (2023)

Mesenchymal stromal cells alleviate acute respiratory distress syndrome through the cholinergic anti-inflammatory pathway
por: Zhang, Xiaoran, et al.
Publicado: (2022)

Anti-cancer effects of nitrogen-containing bisphosphonates on human cancer cells
por: Jiang, Pengfei, et al.
Publicado: (2016)

Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome
por: Hayes, Mairead, et al.
Publicado: (2012)

Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Effect of Infla-Kine supplementation on the gene expression of inflammatory markers in peripheral mononuclear cells and on C-reactive protein in blood
por: Mikirova, Nina A., et al.
Publicado: (2017)

Recent insights: mesenchymal stromal/stem cell therapy for acute respiratory distress syndrome
por: Horie, Shahd, et al.
Publicado: (2016)

The effect of acute respiratory distress syndrome on bone marrow-derived mesenchymal stem cells
por: Antebi, Ben, et al.
Publicado: (2018)

Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics
por: Qin, Hua, et al.
Publicado: (2020)

Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2019)

Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome
por: Han, Jibin, et al.
Publicado: (2019)

Mesenchymal stem cell‐derived extracellular vesicles for the treatment of acute respiratory distress syndrome
por: Abraham, Aswin, et al.
Publicado: (2019)

Mesenchymal Stem Cell: Does it Work in an Experimental Model with Acute Respiratory Distress Syndrome?
por: Yilmaz, Sema, et al.
Publicado: (2012)

Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement
por: Ichim, Thomas E., et al.
Publicado: (2018)

Simultaneous Multiparameter Cellular Energy Metabolism Profiling of Small Populations of Cells
por: Kelbauskas, Laimonas, et al.
Publicado: (2018)

Activity of pemetrexed in pre-clinical chordoma models and humans
por: Kesari, Santosh, et al.
Publicado: (2023)

Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome
por: Wang, Yan-Yang, et al.
Publicado: (2013)

Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome
por: Tovar, Isabel, et al.
Publicado: (2020)

Mesenchymal stem cell use in acute respiratory distress syndrome: a potential therapeutic application
por: Freitag, Julien, et al.
Publicado: (2020)

Therapeutic Benefits of Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome: Potential Mechanisms and Challenges
por: Cao, Chao, et al.
Publicado: (2022)

Mesenchymal Stem Cells for the Compassionate Treatment of Severe Acute Respiratory Distress Syndrome Due to COVID 19
por: Iglesias, Martin, et al.
Publicado: (2021)

Umbilical Cord-derived Mesenchymal Stem Cells with Surfactant Protein B Alleviates Inflammatory Response in Acute Respiratory Distress Syndrome by Regulating Macrophage Polarization
por: Xu, Hongtao, et al.
Publicado: (2022)

Worsening acute respiratory distress syndrome: Is it immune reconstitution inflammatory syndrome?
por: Saroa, Richa, et al.
Publicado: (2013)

Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Supported with Extracorporeal Membrane Oxygenation. Lost in Translational Research?
por: Del Sorbo, Lorenzo, et al.
Publicado: (2020)

Increased mobilization of mesenchymal stem cells in patients with acute respiratory distress syndrome undergoing extracorporeal membrane oxygenation
por: Patry, Christian, et al.
Publicado: (2020)

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment
por: Wang, Wendi, et al.
Publicado: (2021)

Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome
por: Liang, Tian-Yu, et al.
Publicado: (2023)

Treatment of Acute Respiratory Distress Syndrome Caused by COVID-19 with Human Umbilical Cord Mesenchymal Stem Cells
por: Bukreieva, Tetiana, et al.
Publicado: (2023)

RUNX1 mediates the therapeutic effects of mesenchymal stem cells‐derived microparticles in acute respiratory distress syndrome
por: Predescu, Dan, et al.
Publicado: (2023)

The acute respiratory distress syndrome in 2013
por: Matthay, Michael A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vg445ng99juh88q8uvu53u5c23